Renovia Inc., an upstart company co-founded by Marc Beer, the former CEO of Aegerion Pharmaceuticals, has announced that it will be moving forward with a variety of new products for consumers with pelvic floor disorders. These include ailments like urinary incontinence. The first of these products, Leva, gained FDA approval this April.
Beer has worn several hats throughout his long career. Previously, Beer had positions within Genzyme, including Vice President of Global Marketing. He had several marketing and sales jobs within the diagnostic and pharmaceutical branches of Abbot Laboratories. He was a member of the Mass Life Board of the Commonwealth of Massachusetts and served on the Biotechnology Industry Organization Emerging Companies Section Governing Board.
Beer has also been the founding CEO of ViaCell, a company that specializes in the development, preservation, and collection of umbilical cord blood stem cells. While there, he led the company, helping to bring it from a small upstart company and make it into a quickly growing commercial venture. The company would grow to over 300 employees and eventually became a publicly traded company in 2005. Ultimately it would be acquired by Perkin-Elmer. He was also a member of the board of directors of Erytech Pharma.
In addition to these positions, Beers was a member of the Audit committee, chairman of the compensation committee, and Founding chairman of the board of directors for Minerva Neurosciences Inc. Beers was Founding Chairman of the board of directors and chairman of the compensation committee of GoodStart Genetics, Inc. Beer had also previously served as a consultant for OvaScience and was a member of Miami University Business Advisory Council. He was also a member of the Notre Dame Research and Commercialization Advisory Committee and Notre Dame Graduate Studies Research and Advisory Council. Beer has a BS from Miami University in Ohio. Learn more : https://www.slideshare.net/MarcBeer